The ACR is offering new tools to help radiology practices evaluate and monitor imaging AI algorithms.
Key Details
- 1The American College of Radiology is expanding its suite of resources for radiology practices evaluating imaging AI.
- 2A repository now compiles all FDA-cleared, pixel-based AI algorithms for member review.
- 3Over 1,400 clinical algorithms have FDA clearance, with 80% targeting medical imaging.
- 4Hundreds of vendors offer both FDA-cleared and non-regulated imaging AI products.
- 5ACR aims to help radiologists make informed purchasing and adoption decisions given the complexity of the AI landscape.
Why It Matters
As the AI market for medical imaging becomes increasingly crowded, these centralized resources are critical to help radiology practices select safe, effective tools and keep up with rapid advancements. Such efforts by the ACR can drive informed, evidence-based adoption of AI in clinical practice.
Source
Radiology Business
Related News
•HealthExec
Experts Advocate Licensing Model for Clinical AI Regulation
Three prominent medical leaders propose a six-step licensing pathway to govern autonomous clinical AI, drawing direct parallels to physician licensing.
•Radiology Business
AMA Urges Caution on AI for Medical Diagnosis and Treatment
The American Medical Association advises against using AI and chatbots as replacements for physician-led diagnosis and treatment decisions.
•Radiology Business
ACR Approves New Framework for Assessing Imaging AI in Practice
The American College of Radiology Council has approved a new practice parameter to guide the assessment and deployment of AI in imaging.